Loading view.
- No events scheduled for May 5, 2023. Jump to the next upcoming events.
- No events scheduled for May 5, 2023. Jump to the next upcoming events.
Featured Posts
WestGroupe Signs North American Distribution Agreement with IndependentEyewear Brand Sunday Somewhere
Sunday Somewhere, renowned for its bold, oversized 70s-inspired eyewear, has partnered with WestGroupe to expand distribution across the USA and Canada.
Learn More
Advancing Eye Care in Atlantic Canada
University of New Brunswick and University of Waterloo exploring the creation of a school of optometry in Saint John
Read more
First Patients Dosed in Gene Therapy Trial for USH1B
AAVantgarde Bio, an Italy-based biotechnology company announced that the first patient has been dosed in their Phase ½ clinical trial. This trial will test the safety of a new gene therapy (AAVB-081) for Usher Syndrome Type.
Read more
GIGI STUDIOS’ ISOTTA: Timeless Elegance Meets Modern Craftsmanship
Introducing ISOTTA from our VANGUARD collection: a perfect blend of timeless elegance and modern craftsmanship.
Read more
Vision Expo East to Debut New Elevated Experiences and Events in Orlando
Vision Expo East is set to transform and inspire the optical industry with a reimagined show floor and enhanced programming at its inaugural Orlando edition.
Read more
WestGroupe Signs North American Distribution Agreement with IndependentEyewear Brand Sunday Somewhere
Sunday Somewhere, renowned for its bold, oversized 70s-inspired eyewear, has partnered with WestGroupe to expand distribution across the USA and Canada.
Learn More Advancing Eye Care in Atlantic Canada
University of New Brunswick and University of Waterloo exploring the creation of a school of optometry in Saint John
Read More First Patients Dosed in Gene Therapy Trial for USH1B
AAVantgarde Bio, an Italy-based biotechnology company announced that the first patient has been dosed in their Phase ½ clinical trial. This trial will test the safety of a new gene therapy (AAVB-081) for Usher Syndrome Type.
Read More GIGI STUDIOS’ ISOTTA: Timeless Elegance Meets Modern Craftsmanship
Introducing ISOTTA from our VANGUARD collection: a perfect blend of timeless elegance and modern craftsmanship.
Read More Vision Expo East to Debut New Elevated Experiences and Events in Orlando
Vision Expo East is set to transform and inspire the optical industry with a reimagined show floor and enhanced programming at its inaugural Orlando edition.
Read More
WestGroupe Signs North American Distribution Agreement with IndependentEyewear Brand Sunday Somewhere
Sunday Somewhere, renowned for its bold, oversized 70s-inspired eyewear, has partnered with WestGroupe to expand distribution across the USA and Canada.
Learn More Advancing Eye Care in Atlantic Canada
University of New Brunswick and University of Waterloo exploring the creation of a school of optometry in Saint John
Read more First Patients Dosed in Gene Therapy Trial for USH1B
AAVantgarde Bio, an Italy-based biotechnology company announced that the first patient has been dosed in their Phase ½ clinical trial. This trial will test the safety of a new gene therapy (AAVB-081) for Usher Syndrome Type.
Read more GIGI STUDIOS’ ISOTTA: Timeless Elegance Meets Modern Craftsmanship
Introducing ISOTTA from our VANGUARD collection: a perfect blend of timeless elegance and modern craftsmanship.
Read more Vision Expo East to Debut New Elevated Experiences and Events in Orlando
Vision Expo East is set to transform and inspire the optical industry with a reimagined show floor and enhanced programming at its inaugural Orlando edition.
Read more WestGroupe Signs North American Distribution Agreement with IndependentEyewear Brand Sunday Somewhere
Sunday Somewhere, renowned for its bold, oversized 70s-inspired eyewear, has partnered with WestGroupe to expand distribution across the USA and Canada.
Learn More Advancing Eye Care in Atlantic Canada
University of New Brunswick and University of Waterloo exploring the creation of a school of optometry in Saint John
Read more First Patients Dosed in Gene Therapy Trial for USH1B
AAVantgarde Bio, an Italy-based biotechnology company announced that the first patient has been dosed in their Phase ½ clinical trial. This trial will test the safety of a new gene therapy (AAVB-081) for Usher Syndrome Type.
Read more GIGI STUDIOS’ ISOTTA: Timeless Elegance Meets Modern Craftsmanship
Introducing ISOTTA from our VANGUARD collection: a perfect blend of timeless elegance and modern craftsmanship.
Read more Vision Expo East to Debut New Elevated Experiences and Events in Orlando
Vision Expo East is set to transform and inspire the optical industry with a reimagined show floor and enhanced programming at its inaugural Orlando edition.
Read more